tiprankstipranks
SELLAS Life Sciences Group (SLS)
NASDAQ:SLS
Holding SLS?
Track your performance easily

SELLAS Life Sciences Group (SLS) Financial Statements

886 Followers

SELLAS Life Sciences Group Financial Overview

SELLAS Life Sciences Group's market cap is currently ―. The company's EPS TTM is $-0.7; its P/E ratio is -1.61; SELLAS Life Sciences Group is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.11M$ -7.47M$ -9.64M$ -8.18M$ -9.36M
EBITDA$ -6.97M$ -7.33M$ -9.51M$ -8.05M$ -9.36M
Net Income Common Stockholders$ -7.11M$ -7.47M$ -9.57M$ -8.14M$ -9.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.00M$ 9.10M$ 18.40M$ 2.53M$ 4.00M
Total Assets$ 26.50M$ 15.12M$ 24.43M$ 6.22M$ 8.09M
Total Debt$ 576.00K$ 692.00K$ 801.00K$ 906.00K$ 644.00K
Net Debt$ -20.42M$ -8.41M$ -17.60M$ -1.62M$ -3.36M
Total Liabilities$ 10.61M$ 12.21M$ 14.75M$ 14.20M$ 11.91M
Stockholders Equity$ 15.89M$ 2.91M$ 9.68M$ -7.98M$ -3.83M
Cash Flow-
Free Cash Flow$ -7.80M$ -9.60M$ -10.80M$ -4.80M$ -9.89M
Operating Cash Flow$ -7.80M$ -9.60M$ -10.80M$ -4.80M$ -6.89M
Investing Cash Flow----$ -3.00M
Financing Cash Flow$ 19.69M$ 414.00K$ 26.65M$ 3.39M$ 54.00K
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

SELLAS Life Sciences Group Debt to Assets

SELLAS Life Sciences Group Cash Flow

SELLAS Life Sciences Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis